The Inflammation Test Kit Market is developing steadily as healthcare providers place greater emphasis on the early identification and monitoring of inflammatory conditions. Inflammation testing can support the assessment of conditions such as rheumatoid arthritis, cardiovascular diseases, cancer, and inflammatory bowel disease.

According to Wise Guy Reports, the global market was valued at around USD 2 billion in 2025 and is projected to reach approximately USD 4 billion by 2035, expanding at a CAGR of 5.9% from 2026 to 2035.

One of the major factors supporting market development is the increasing prevalence of chronic and inflammatory disorders. As healthcare professionals seek faster and more reliable diagnostic information, demand for testing solutions is expanding across hospitals, diagnostic laboratories, research institutions, and homecare settings.

Technological progress is also influencing the industry. Modern testing systems are increasingly incorporating automation, advanced analytics, and other digital capabilities to improve testing efficiency. Point-of-care testing is gaining attention because it can provide results closer to the time and location of patient care.

The market includes several test categories, including C-reactive protein, erythrocyte sedimentation rate, interleukin, and tumor necrosis factor tests. Test kits, reagents, and analyzers form the primary product categories.

With continued investment in diagnostic technology and growing awareness of inflammation-related diseases, the market is expected to present opportunities for manufacturers, laboratories, healthcare providers, and technology companies.